Rare diseases
Investigational molecules
Locations
Study of PF-07275315 to evaluate its effectiveness and safety in adults with moderate-to-severe asthma who have high levels of eosinophils in their blood
BelgiumStudy of BMS-986368 to treat muscle stiffness in people with Multiple Sclerosis
CzechiaStudy of ibuzatrelvir alone or combined with remdesivir in adults with COVID-19 who have severely compromised immune systems
BelgiumStudy of carboplatin, paclitaxel, and tislelizumab treatment in patients with resectable locally advanced oral cavity squamous cell carcinoma
ItalyComparing two forms of mupirocin (gel and ointment) for treating impetigo in children: a study of different dosing schedules
SpainStudy of MK-1084, cetuximab and mFOLFOX6 combination compared to mFOLFOX6 with or without bevacizumab for patients with KRAS G12C-mutant advanced colorectal cancer
FinlandStudy of Remternetug for Prevention of Disease Progression in People at Risk for or With Early Onset Inherited Alzheimer's Disease
FranceStudy of mirvetuximab soravtansine dosing schedules for patients with platinum-resistant advanced ovarian, peritoneal, or fallopian tube cancer with high folate receptor expression
BelgiumStudy of ABBV-453 alone or with drug combination for adults with multiple myeloma: evaluation of safety and effectiveness
BelgiumStudy of sonrotoclax plus obinutuzumab or rituximab compared to venetoclax plus rituximab in patients with relapsed or refractory chronic lymphocytic leukemia
AustriaA study of Pseudovax, molgramostim and tislelizumab combination therapy for patients with pseudomyxoma peritonei cancer
NorwayStudy of trastuzumab deruxtecan with bevacizumab versus bevacizumab alone as first-line maintenance treatment for patients with HER2-expressing ovarian cancer
AustriaTell us about your condition – we search every trial in Europe and connect you with the right site.
